RORA and cutaneous melanoma: We found that BHLHE41 and TIMELESS were upregulated in skin cutaneous melanoma patients, while BMAL1, BHLHE40, CRY2, HLF, NFIL3, NR1D1, PER1, PER2, PER3, RORA, RORC and TEF were downregulated.